ESLOF
Price
$355.20
Change
+$42.95 (+13.76%)
Updated
Oct 16 closing price
Capitalization
144.57B
ESLOY
Price
$177.13
Change
+$19.21 (+12.16%)
Updated
Oct 16 closing price
Capitalization
144.57B
140 days until earnings call
Interact to see
Advertisement

ESLOF vs ESLOY

Header iconESLOF vs ESLOY Comparison
Open Charts ESLOF vs ESLOYBanner chart's image
EssilorLuxottica
Price$355.20
Change+$42.95 (+13.76%)
Volume$732
Capitalization144.57B
EssilorLuxottica
Price$177.13
Change+$19.21 (+12.16%)
Volume$59.15K
Capitalization144.57B
ESLOF vs ESLOY Comparison Chart in %
ESLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESLOF vs. ESLOY commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLOF is a Hold and ESLOY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (ESLOF: $355.20 vs. ESLOY: $177.13)
Brand notoriety: ESLOF and ESLOY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ESLOF: 57% vs. ESLOY: 139%
Market capitalization -- ESLOF: $144.57B vs. ESLOY: $144.57B
ESLOF [@Pharmaceuticals: Other] is valued at $144.57B. ESLOY’s [@Pharmaceuticals: Other] market capitalization is $144.57B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $155.8B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLOF’s FA Score shows that 2 FA rating(s) are green whileESLOY’s FA Score has 2 green FA rating(s).

  • ESLOF’s FA Score: 2 green, 3 red.
  • ESLOY’s FA Score: 2 green, 3 red.
According to our system of comparison, both ESLOF and ESLOY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLOF’s TA Score shows that 6 TA indicator(s) are bullish while ESLOY’s TA Score has 5 bullish TA indicator(s).

  • ESLOF’s TA Score: 6 bullish, 2 bearish.
  • ESLOY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ESLOF is a better buy in the short-term than ESLOY.

Price Growth

ESLOF (@Pharmaceuticals: Other) experienced а +7.05% price change this week, while ESLOY (@Pharmaceuticals: Other) price change was +10.55% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.75%. For the same industry, the average monthly price growth was +0.04%, and the average quarterly price growth was +13.98%.

Reported Earning Dates

ESLOY is expected to report earnings on Mar 06, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-0.75% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLOF($145B) and ESLOY($145B) have the same market capitalization . ESLOF (59.45) and ESLOY (59.29) have similar P/E ratio . ESLOY YTD gains are higher at: 51.690 vs. ESLOF (47.846). ESLOF (6.71B) and ESLOY (6.71B) have comparable annual earnings (EBITDA) . ESLOF (3.16B) and ESLOY (3.16B) have equal amount of cash in the bank . ESLOF (14B) and ESLOY (14B) have identical debt. ESLOF (27.2B) and ESLOY (27.2B) have equivalent revenues.
ESLOFESLOYESLOF / ESLOY
Capitalization145B145B100%
EBITDA6.71B6.71B100%
Gain YTD47.84651.69093%
P/E Ratio59.4559.29100%
Revenue27.2B27.2B100%
Total Cash3.16B3.16B100%
Total Debt14B14B100%
FUNDAMENTALS RATINGS
ESLOF vs ESLOY: Fundamental Ratings
ESLOF
ESLOY
OUTLOOK RATING
1..100
6189
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
60
Fair valued
PROFIT vs RISK RATING
1..100
149
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8585
P/E GROWTH RATING
1..100
1616
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESLOF's Valuation (60) in the null industry is in the same range as ESLOY (60). This means that ESLOF’s stock grew similarly to ESLOY’s over the last 12 months.

ESLOY's Profit vs Risk Rating (9) in the null industry is in the same range as ESLOF (14). This means that ESLOY’s stock grew similarly to ESLOF’s over the last 12 months.

ESLOY's SMR Rating (100) in the null industry is in the same range as ESLOF (100). This means that ESLOY’s stock grew similarly to ESLOF’s over the last 12 months.

ESLOY's Price Growth Rating (85) in the null industry is in the same range as ESLOF (85). This means that ESLOY’s stock grew similarly to ESLOF’s over the last 12 months.

ESLOY's P/E Growth Rating (16) in the null industry is in the same range as ESLOF (16). This means that ESLOY’s stock grew similarly to ESLOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ESLOFESLOY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 9 days ago
66%
Bullish Trend 15 days ago
59%
Declines
ODDS (%)
Bearish Trend 5 days ago
53%
Bearish Trend 3 days ago
48%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
46%
Aroon
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
ESLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IAC32.85-0.44
-1.32%
IAC
CTRA22.58-0.62
-2.67%
Coterra Energy
MATV10.79-0.33
-2.97%
Mativ Holdings
FSI8.84-0.30
-3.28%
Flexible Solutions International
HCWB4.02-0.32
-7.37%
HCW Biologics Inc

ESLOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOF has been loosely correlated with ESLOY. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOF jumps, then ESLOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOF
1D Price
Change %
ESLOF100%
+13.76%
ESLOY - ESLOF
58%
Loosely correlated
+12.16%
SAUHF - ESLOF
39%
Loosely correlated
N/A
SMMNY - ESLOF
32%
Poorly correlated
+1.10%
NVCR - ESLOF
27%
Poorly correlated
-1.06%
MASS - ESLOF
24%
Poorly correlated
+0.93%
More

ESLOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOY
1D Price
Change %
ESLOY100%
+12.16%
ESLOF - ESLOY
58%
Loosely correlated
+13.76%
QGEN - ESLOY
43%
Loosely correlated
+1.30%
ALC - ESLOY
38%
Loosely correlated
+1.91%
SMMNY - ESLOY
38%
Loosely correlated
+1.10%
CRL - ESLOY
35%
Loosely correlated
+2.48%
More